Cargando…

HIV testing and burden of HIV infection in black cancer patients in Johannesburg, South Africa: a cross-sectional study

BACKGROUND: HIV infection is a known risk factor for cancer but little is known about HIV testing patterns and the burden of HIV infection in cancer patients. We did a cross-sectional analysis to identify predictors of prior HIV testing and to quantify the burden of HIV in black cancer patients in J...

Descripción completa

Detalles Bibliográficos
Autores principales: Sengayi, Mazvita, Babb, Chantal, Egger, Matthias, Urban, Margaret I
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4434805/
https://www.ncbi.nlm.nih.gov/pubmed/25884599
http://dx.doi.org/10.1186/s12885-015-1171-7
_version_ 1782371798379134976
author Sengayi, Mazvita
Babb, Chantal
Egger, Matthias
Urban, Margaret I
author_facet Sengayi, Mazvita
Babb, Chantal
Egger, Matthias
Urban, Margaret I
author_sort Sengayi, Mazvita
collection PubMed
description BACKGROUND: HIV infection is a known risk factor for cancer but little is known about HIV testing patterns and the burden of HIV infection in cancer patients. We did a cross-sectional analysis to identify predictors of prior HIV testing and to quantify the burden of HIV in black cancer patients in Johannesburg, South Africa. METHODS: The Johannesburg Cancer Case–control Study (JCCCS) recruits newly-diagnosed black cancer patients attending public referral hospitals for oncology and radiation therapy in Johannesburg . All adult cancer patients enrolled into the JCCCS from November 2004 to December 2009 and interviewed on previous HIV testing were included in the analysis. Patients were independently tested for HIV-1 using a single ELISA test . The prevalence of prior HIV testing, of HIV infection and of undiagnosed HIV infection was calculated. Multivariate logistic regression models were fitted to identify factors associated with prior HIV testing. RESULTS: A total of 5436 cancer patients were tested for HIV of whom 1833[33.7% (95% CI=32.5-35.0)] were HIV-positive. Three-quarters of patients (4092 patients) had ever been tested for HIV. The total prevalence of undiagnosed HIV infection was 11.5% (10.7-12.4) with 34% (32.0–36.3) of the 1833 patients who tested HIV-positive unaware of their infection. Men >49 years [OR 0.49(0.39–0.63)] and those residing in rural areas [OR 0.61(0.39–0.97)] were less likely to have been previously tested for HIV. Men with at least a secondary education [OR 1.79(1.11–2.90)] and those interviewed in recent years [OR 4.13(2.62 – 6.52)] were likely to have prior testing. Women >49 years [OR 0.33(0.27–0.41)] were less likely to have been previously tested for HIV. In women, having children <5 years [OR 2.59(2.04–3.29)], hormonal contraceptive use [OR 1.33(1.09–1.62)], having at least a secondary education [OR:2.08(1.45–2.97)] and recent year of interview [OR 6.04(4.45–8.2)] were independently associated with previous HIV testing. CONCLUSIONS: In a study of newly diagnosed black cancer patients in Johannesburg, over a third of HIV-positive patients were unaware of their HIV status. In South Africa black cancer patients should be targeted for opt-out HIV testing. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12885-015-1171-7) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-4434805
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-44348052015-05-19 HIV testing and burden of HIV infection in black cancer patients in Johannesburg, South Africa: a cross-sectional study Sengayi, Mazvita Babb, Chantal Egger, Matthias Urban, Margaret I BMC Cancer Research Article BACKGROUND: HIV infection is a known risk factor for cancer but little is known about HIV testing patterns and the burden of HIV infection in cancer patients. We did a cross-sectional analysis to identify predictors of prior HIV testing and to quantify the burden of HIV in black cancer patients in Johannesburg, South Africa. METHODS: The Johannesburg Cancer Case–control Study (JCCCS) recruits newly-diagnosed black cancer patients attending public referral hospitals for oncology and radiation therapy in Johannesburg . All adult cancer patients enrolled into the JCCCS from November 2004 to December 2009 and interviewed on previous HIV testing were included in the analysis. Patients were independently tested for HIV-1 using a single ELISA test . The prevalence of prior HIV testing, of HIV infection and of undiagnosed HIV infection was calculated. Multivariate logistic regression models were fitted to identify factors associated with prior HIV testing. RESULTS: A total of 5436 cancer patients were tested for HIV of whom 1833[33.7% (95% CI=32.5-35.0)] were HIV-positive. Three-quarters of patients (4092 patients) had ever been tested for HIV. The total prevalence of undiagnosed HIV infection was 11.5% (10.7-12.4) with 34% (32.0–36.3) of the 1833 patients who tested HIV-positive unaware of their infection. Men >49 years [OR 0.49(0.39–0.63)] and those residing in rural areas [OR 0.61(0.39–0.97)] were less likely to have been previously tested for HIV. Men with at least a secondary education [OR 1.79(1.11–2.90)] and those interviewed in recent years [OR 4.13(2.62 – 6.52)] were likely to have prior testing. Women >49 years [OR 0.33(0.27–0.41)] were less likely to have been previously tested for HIV. In women, having children <5 years [OR 2.59(2.04–3.29)], hormonal contraceptive use [OR 1.33(1.09–1.62)], having at least a secondary education [OR:2.08(1.45–2.97)] and recent year of interview [OR 6.04(4.45–8.2)] were independently associated with previous HIV testing. CONCLUSIONS: In a study of newly diagnosed black cancer patients in Johannesburg, over a third of HIV-positive patients were unaware of their HIV status. In South Africa black cancer patients should be targeted for opt-out HIV testing. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12885-015-1171-7) contains supplementary material, which is available to authorized users. BioMed Central 2015-03-18 /pmc/articles/PMC4434805/ /pubmed/25884599 http://dx.doi.org/10.1186/s12885-015-1171-7 Text en © Sengayi et al.; licensee BioMed Central. 2015 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Sengayi, Mazvita
Babb, Chantal
Egger, Matthias
Urban, Margaret I
HIV testing and burden of HIV infection in black cancer patients in Johannesburg, South Africa: a cross-sectional study
title HIV testing and burden of HIV infection in black cancer patients in Johannesburg, South Africa: a cross-sectional study
title_full HIV testing and burden of HIV infection in black cancer patients in Johannesburg, South Africa: a cross-sectional study
title_fullStr HIV testing and burden of HIV infection in black cancer patients in Johannesburg, South Africa: a cross-sectional study
title_full_unstemmed HIV testing and burden of HIV infection in black cancer patients in Johannesburg, South Africa: a cross-sectional study
title_short HIV testing and burden of HIV infection in black cancer patients in Johannesburg, South Africa: a cross-sectional study
title_sort hiv testing and burden of hiv infection in black cancer patients in johannesburg, south africa: a cross-sectional study
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4434805/
https://www.ncbi.nlm.nih.gov/pubmed/25884599
http://dx.doi.org/10.1186/s12885-015-1171-7
work_keys_str_mv AT sengayimazvita hivtestingandburdenofhivinfectioninblackcancerpatientsinjohannesburgsouthafricaacrosssectionalstudy
AT babbchantal hivtestingandburdenofhivinfectioninblackcancerpatientsinjohannesburgsouthafricaacrosssectionalstudy
AT eggermatthias hivtestingandburdenofhivinfectioninblackcancerpatientsinjohannesburgsouthafricaacrosssectionalstudy
AT urbanmargareti hivtestingandburdenofhivinfectioninblackcancerpatientsinjohannesburgsouthafricaacrosssectionalstudy